The presence of hypoxic regions in solid tumors is an adverse prognostic factor for patient outcome. Here, we show that hypoxia induces the expression of Ephrin-A3 through a novel hypoxia-inducible factor (HIF)-mediated mechanism. In response to hypoxia, the coding EFNA3 mRNA levels remained relatively stable, but HIFs drove the expression of previously unknown long noncoding (lnc) RNAs from EFNA3 locus and these lncRNA caused Ephrin-A3 protein accumulation. Ephrins are cell surface proteins that regulate diverse biological processes by modulating cellular adhesion and repulsion. Mounting evidence implicates deregulated ephrin function in multiple aspects of tumor biology. We demonstrate that sustained expression of both Ephrin-A3 and novel EFNA3 lncRNAs increased the metastatic potential of human breast cancer cells, possibly by increasing the ability of tumor cells to extravasate from the blood vessels into surrounding tissue. In agreement, we found a strong correlation between high EFNA3 expression and shorter metastasis-free survival in breast cancer patients. Taken together, our results suggest that hypoxia could contribute to metastatic spread of breast cancer via HIF-mediated induction of EFNA3 lncRNAs and subsequent Ephrin-A3 protein accumulation.
INTRODUCTION
In a variety of pathologic situations, oxygen demand exceeds its supply to affected tissues leading to a condition known as hypoxia. In particular, hypoxia is frequently observed in solid tumors and, importantly, it has been suggested to be an adverse prognostic factor for patient outcome. 1, 2 At the cellular level, oxygen homeostasis is largely dependent on the induction of a specific gene expression program under the control of the hypoxia-inducible factors (HIFs). HIFs are heterodimers composed of αand β-subunits that belong to the basic helix-loop-helix Per-ARNT-Sim family. 3 In mammals, three genes encode HIFα subunits, HIF1A, EPAS1/HIF2A and HIF3A, of which HIF-1α and EPAS1 are the best characterized. 4 Oxygen regulates the stability 5, 6 and transcriptional activity [7] [8] [9] of HIFα without affecting HIFβ function. The induction of the HIF transcriptional program results in cellular adaptation to hypoxia, a response that aims to restore oxygen supply to hypoxic regions through the induction of erythropoiesis and angiogenesis and to reduce oxygen consumption by reprogramming cellular metabolism.
HIFs role in cancer has been extensively investigated. On the one hand, as hypoxia develops in tumors due to the rapid expansion of the transformed cells, HIF is activated contributing to critical aspects of tumor progression. 1, 10 On the other hand, von Hippel-Lindau (VHL) tumor suppressor, which has a key role in the control of HIFα stability, [11] [12] [13] is frequently lost in clear-cell renal cell carcinomas (ccRCC). Moreover, several lines of evidence point to HIFs, in particular EPAS1, as an ethiologic factor in this kind of cancer. 14 Other oncogenes and tumor suppressor genes including PTEN, mTORC1, Ras, Akt and p53 also regulate the HIF activity. 15 Importantly, the correlation between tumor hypoxia and/or HIFα expression with poor prognosis and increased risk of metastasis has been repeatedly demonstrated in diverse tumor types. 2 Not surprisingly, many of the HIF target genes are involved in biologic processes that impact the metastatic spread of cancer cells, such as angiogenesis, epithelial-mesenchymal transition, cell motility, intra/extravasation and control of the premetastatic niche. 16 Ephrins are a large family of cell surface ligands that mediate intercellular adhesion and repulsion through interaction with a large group of receptor tyrosine kinases, the Eph receptors. 17, 18 Ephrins play essential roles during development, where they guide migration and positioning of the cells for proper tissue patterning. Their function has been particularly well characterized in the nervous system, where Ephrins/Eph function as axon guidance molecules, and in the cardiovascular system, where they control vasculogenesis and angiogenesis. 17 Ephrins are separated into two families according to their structure. Type A Ephrins (Ephrin-A1 to -A5) are glycosylphosphatidyl-inositol-linked membrane-bound ligands, whereas type B ephrins (Ephrin-B1 to -B3) contain a single transmembrane domain and a short cytoplasmic tail. 19 Interestingly, many of the biologic functions of ephrins and Ephs are co-opted by transformed cells and contribute to tumor progression. 20 Accordingly, many ephrin family members are altered in human cancers and their expression often correlates with a more aggressive phenotype, invasion, metastasis and poor prognosis. 21 In addition to their role in adhesion and repulsion, Eph/Ephrins may contribute to tumor progression and metastasis by altering angiogenesis. 21 Intriguingly, HIF-dependent regulation of Ephrin-A1, Ephrin-B2, Figure 1 . Hypoxia regulates EFNA3 expression. (a) Ephrin-A3 protein level was determined in HeLa, HUVEC, MCF-7 and MDA-MB231 cells were exposed to normoxia (21% oxygen) or hypoxia (1% oxygen) for the indicated periods of time. (b) Diagram of the EFNA3 locus showing the canonical, NM_004952 RefSeq, gene (upper track, EFNA3) and the novel isoforms (second track from the top, NC1-NC2s). The bottom tracks show the position of the qPCR oligonucleotides used in Figures 1d-g (black boxes) and target regions (thin lines). The figure was generated by the UCSC genome browser upon loading the indicated custom tracks. (c) cDNAs corresponding to EFNA3, NC1 or NC2 isoforms were transcribed and translated in vitro in the presence of 35 S-methionine and proteins resolved in a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Image shows the autoradiogram of a representative experiment. (d) HeLa cells were transfected with plasmids encoding for the indicated EFNA3 isforms and cell lysates probed with monoclonal (mAb) or polyclonal (pAb) antibodies against the C-terminal region of human Ephrin-A3. (e) HeLa cells were exposed to 1% oxygen (Hyp) or left at normoxic conditions (Nx) for 12 h and EFNA3 RNA levels were determined using the indicated TaqMan probes (see panel b). The graph shows the ratio of EFNA3 to ACTB (β-actin) copy number. Bars represent the mean of three independent biologic replicates and the error bars the s.d. The differences between groups were statistically significant (analysis of variance (ANOVA) F 3,8 = 34.21, P o0.001) and the asterisks indicate means pairs that were the statistically significant (adjusted Po 0.001) in a posteriori Tukey's test. (f) Cells were treated as in (e) and EFNA3 RNA levels were determined using the indicated primer pairs (see panel b). The graph shows the ratio of hypoxic EFNA3 RNA to the expression in normoxia. Symbols represent the mean of three independent biologic replicates and the error bars the s.d. (g) HeLa cells were treated with the indicated siRNAs and then grown at normoxic (21% oxygen, Nx) or hypoxic (1% oxygen, Hyp) conditions for 12 h. The graph represent the normalized levels of EFNA3 RNA as fold over control conditions (normoxic cells treated with scramble siRNA). Bars represent average values in four independent biologic replicates and error bars the s.d. The differences between groups were statistically significant (ANOVA F 7,48 = 23.52, Po 0.001) and the asterisks indicate means pairs that were statistically significant (***adjusted Po 0.001) in a posteriori Tukey's test. (h) Vhlfl/fl-UBC-Cre-ERT2 (n = 5), Vhlfl/flHIF2αfl/ fl-UBC-Cre-ERT2 (n = 3) and control (n = 11) mice were placed on a tamoxifen diet for 10 days followed by 10 additional days on a normal diet. The box-and-whisker plot represents the distribution of the normalized EFNA3 RNA expression in the liver of animals with the indicated genotypes. The box contains the values comprised between the second and third quartiles, and the horizontal black line the median. The 'whiskers' extend to 1.5 times the interquartile range. The differences between groups were statistically significant (ANOVA F 2,18 = 20.49, Po0.001) and the asterisks indicate means pairs that were statistically significant (adjusted P o0.001) in a posteriori Tukey's test.
EphA2 and EphA4 has been described in a mouse model of skin hypoxia, 22 suggesting a potential link between intratumoral hypoxia, ephrin/Eph expression and tumor progression. In agreement, Ephrin-A1 is upregulated at the transcription level, via EPAS1, in hypoxic tumors and this upregulation contributes to increased tumor vascularization. 23, 24 Altogether, these works suggest a link between tumoral hypoxia and progression to aggressive phenotype via HIF-mediated regulation of Ephrin expression.
In this study, we show that hypoxia leads to Ephrin-A3 protein accumulation via a previously unknown mechanism that involves HIF-mediated transcriptional upregulation of a novel group of lncRNAs encoded by the EFNA3 locus. Using animal models and in vitro assays, we demonstrate that Ephrin-A3 expression leads to metastatic spread. In contrast with previous studies, we observed no effect on vascularization, but a strong repulsive action, which leads to increased intra-and extravasation that underlies the promotion of metastatic spread by EFNA3. Finally, the analysis of public gene expression profiling data sets revealed that EFNA3 is induced by HIF in human tumors and this induction is predictive of poor prognosis and increased risk of metastasis.
RESULTS

EFNA3 locus encodes lncRNAs that are regulated by hypoxia
We first identified EFNA3, a member of the ephrin type A ligands, as the potential novel HIF target gene using an in silico search. 25 As a first step to validate this prediction, we determined the level of Ephrin-A3 protein and found that it was induced by hypoxia in several cell lines ( Figure 1a ). The Ephrin-A3 species we detected had an apparent molecular weight of approximately 72 kDa, much higher than the 26.3 kDa molecular weight predicted from its amino-acid sequence, owing to posttranslational modifications (Supplementary Figure 1 ). Next, we decided to study the effect of hypoxia on EFNA3 mRNA. According to curated databases (RefSeq), the EFNA3 locus encodes for a single mRNA isoform (NM_004952). However, inspection of the publicly available information, including expressed sequence tags s and experimentally identified transcription start sites (TSSs) (http://dbtss.hgc.jp/), suggested the existence of additional mRNAs transcribed from this locus. To identify the hypothetical RNA isoforms encoded by the EFNA3 locus, we performed 5'-RACE (5'-rapid amplification of cDNA ends) experiments in HeLa and LoVo cell lines (Supplementary Figure 2 ) and found two TSSs in addition to that of the NM_004952 mRNA ( Figure 1b ). The existence and location of these additional TSSs was supported by 5' cap analysis gene expression tags from multiple cell lines produced as part of the ENCODE Transcriptome Project (Supplementary Figure 2) . Interestingly, none of these novel RNAs seemed to encode for functional proteins and, accordingly, we termed them noncoding-1 (NC1) and NC2, based on their different TSSs ( Figure 1b ). Specifically, NC1 isoform contains an ATG codon within its first 10 nucleotides that is in frame with the open reading frames of NM_004952, suggesting that NC1 could encode a truncated form of Ephrin A3. However, this potential product would have an interrupted structural domain (the ephrin domain) that makes up the bulk of the protein, which would likely undermine its stability. On the other hand, the NC2 sequence does not contain any open reading frames of significant length. In agreement, in vitro transcription-coupled translation of EFNA3 and NC1 cDNAs produced the proteins of expected sizes, whereas NC2 cDNA generated no apparent protein product (Figure 1c and Supplementary Figure 3A) . To test the coding potential of NC1 and NC2 in intact cells, we transfected HeLa cells with the respective plasmids along with the canonical EFNA3 cDNA (EFNA3) (Figure 1d and Supplementary Figures 3B and C) . Neither NC1 nor NC2 caused the expression of exogenous protein that could be recognized by the monoclonal or polyclonal antibody against EFNA3. Thus, NC1 and NC2 can be considered novel lncRNAs. In addition to the novel TSS, a method using support vector machine for poly(A) site prediction 26 identifies two potential 3' ends for this locus (Supplementary Figure 2 ; 'Poly(A) Sites' track). In agreement, analysis of paired-end diTag (PET) sequencing data from ENCODE 27 indicates that all combinations of the TSSs and 3′ ends are present in cells ( Supplementary Figure 2 ; 'GIS-PET' track). Thus, both NC1 and NC2 can be expressed as shorter forms with a truncated 3'-untranslated region, which we termed NC1s and NC2s, respectively ( Figure 1b ).
We next investigated the regulation by hypoxia of the different transcripts encoded by the EFNA3 locus. First, we used commercially available TaqMan probes to amplify the regions of the EFNA3 gene specific to the canonical EFNA3 mRNA (TaqMan1+2; Figure 1e ) and a region common to all the RNA isoforms encoded by this locus (TaqMan4+5; Figure 1e ). Quantitative PCR (qPCR) results indicate that the absolute expression levels and relative induction in response to hypoxia varied widely between RNA species (Figure 1e ). The expression of the canonical coding isoform was low, compared with the combined expression level for all isoforms, suggesting that under normoxic conditions the transcription of the lncRNAs predominates. This result was confirmed by the ENCODE genome-wide transcription analysis (Supplementary Figure 2 ; 'Transcription' track). Strikingly, the canonical EFNA3 isoform was barely induced in response to hypoxia, in stark contrast with the robust upregulation of the bulk of EFNA3 RNAs (Figure 1e ). This result suggested that the lncRNAs, but not the canonical mRNA, were regulated by hypoxia. To confirm this possibility, we designed primer pairs for all the exons in the gene to determine the response to hypoxia of every potential RNA isoform. Indeed, hypoxia strongly upregulated the novel lncRNA isoforms, whereas the regulation of the canonical protein-coding mRNA was only marginal (Figure 1f ). Importantly, the induction of EFNA3 transcripts in response to hypoxia was mediated by HIF as it was blocked by small interfering RNA (siRNA) directed against HIF1α (Figure 1g and Supplementary Figure 4 ). To investigate the regulation of EFNA3 by HIF in vivo, we used conditional VHL-knockout mouse lines. 28 VHL deletion results in constitutive HIF activity and, consistently with the in vitro results, this led to increased EFNA3 lncRNA expression without significantly altering the level of the coding EFNA3 mRNA ( Figure 1h ). Importantly, the induction of EFNA3 upon VHL loss was partially prevented in animals lacking both VHL and EPAS (HIF2α) alleles ( Figure 1h ), suggesting that the in vivo HIF2α regulates EFNA3 expression, at least in the liver and the lung. Regardless of the specific HIF isoform involved, which could just reflect their differential tissue expression, it is clear from these set of results that EFNA3 expression is induced, both in vitro and in vivo, in response to hypoxia, in an HIF-dependent manner.
Mounting evidence indicates that lncRNAs are key regulators of gene expression that affect mRNA transcription rate, stability and translation. 29, 30 Thus, in an attempt to reconcile the induction of Ephrin-A3 protein with the regulation of coding and noncoding transcripts by hypoxia, we tested whether NC1 and NC2 lncRNAs could affect EFNA3 mRNA or protein levels. As shown in Figure 2a , the overexpression of the lncRNAs (Supplementary Figure 5A ) had no significant effect on EFNA3 mRNA levels. However, exogenous expression of NC1/2, particularly the short isoforms (NC1s and NC2s), caused EFNA3 protein accumulation (Figures 2b and c) . To confirm these results, we infected MDA-MB-231 cells with lentivirus encoding for the EFNA3-derived lncRNAs (Supplementary Figure 5B ) and found a dose-dependent effect of viral infection on Ephrin-A3 protein levels ( Figure 2d ). These results provide an explanation for the induction of EFNA3 protein under hypoxia in spite of its modest effect on EFNA3 mRNA level. As for the mechanism by which EFNA3 lncRNA promote Ephrin-A3 protein accumulation, we disregarded an effect on protein stability because Ephrin-A3 has a long half-life (over 22 h in HeLa cells, data not shown) and instead considered the possibility that they could affect Ephrin-A3 translation. It is known that miR-210, which is induced by hypoxia, 31, 32 prevents the translation of several mRNA including ISCU and EFNA3. [33] [34] [35] [36] As miR-210 binds the 3'-untranslated region of the EFNA3 mRNA, 34 it is feasible that EFNA3 lncRNAs increase EFNA3 mRNA translation by depleting miR-210 and other microRNAs (miRNAs) that target the EFNA3 3'-untranslated region ( Supplementary Figure 2A ; TargetScan miRNA track). To test this possibility, we interfered with the miRNA processing machinery by knocking down DGCR8, an essential component of the microprocessor complex. 37 As shown in Figure 2e , the interference of DGCR8 in normoxia resulted in Ephrin-A3 protein accumulation without significantly altering EFNA3 mRNA levels (Figure 2f and Supplementary Figure 5C ). Moreover, DGCR8 silencing does result in a further increase in Ephrin-A3 protein levels under hypoxia (Figure 2e ), suggesting that lncRNAs and miR-210 act on the same pathway Thus, we propose a mechanism by which hypoxia induces EFNA3 lncRNAs that act as endogenous competing RNAs that relieve EFNA3 mRNA from miRNA inhibition allowing for efficient transcription.
HIF binding to an intragenic regulatory region induces the transcription of EFNA3 lncRNAs and, indirectly, regulates Ephrin-A3 expression posttranscriptionally The different TSSs of the EFNA3 isoforms suggested the existence of alternative promoters. In agreement, histone modifications landscape, location of the open chromatin and transcription factor binding site regions in the EFNA3 locus ( Figure 3a) were consistent with the existence of two promoter regions (Figure 3a ), Prm1and Prm2. To further investigate the regulation of the different EFNA3 transcripts, we analyzed the binding of RNA polymerase II (Pol II) to these putative promoter regions. As controls, we also included the promoter regions of a bona fide hypoxia-inducible gene (P4HA) and a non-responsive gene (STT3A). Chromatin The differences between groups was statistically significant (ANOVA F 5,11 = 8.635, P o0.01) and the asterisks indicate sample means that were was significantly different from controls (pLOC samples) in a posteriori Tukey's test (*adjusted Po 0.05; **adjusted Po 0.01). The image in (b) is representative of at least three independent experiments. (d) MDA-MB-231 cells were infected with lentivus encoding for the indicated constructs at different multiplicity of infection (MOI) and the level of Eprhin-A3 protein was determined by immunoblot. A representative experiment of at least three independent biologic replicas is shown. (e) MDA-MB-231 cells were infected with lentiviruses encoding for short hairpin RNA (shRNA) against DGCR8 (shDGCR8) or control shRNA (shControl) and the level of Eprhin-A3 protein was determined by immunoblot. A representative experiment of two independent biologic replicas is shown. (f) The level of DGCR8 mRNA (DGCR8), EFNA3 mRNA (EFNA3, exon 1+2) or NC2/NC2 lncRNA (EFNA3, intron 2) in the experiment shown in (d) were determined by qPCR.
immunoprecipitation-qPCR (ChIP-qPCR) analysis showed that Pol II bound to both regions of the EFNA3 gene locus under normoxia (Figure 3b ). Consistent with the relatively low EFNA3 expression in HeLa cells, the binding of Pol II to the EFNA3 promoter regions was lower than its binding to the P4HA and STT3A promoters. Importantly, Pol II binding to the Prm2 region was strongly induced by hypoxia (Figure 3b) , to a level comparable to the HIF-responsive promoter of P4HA. In contrast, the Pol II binding to the Prm1 region and to the STT3A promoter remained unaffected by hypoxia (Figure 3b ).
Next, we investigated direct binding of HIF1α to the EFNA3 locus by ChIP-qPCR. We designed six primer sets (Figure 3a) , H1-H6, to sample most of the RCGTG motifs (Figure 3a ; 'RCGTG motifs' track) within EFNA3 locus and found that the only fragment that showed significant HIF binding under hypoxic conditions was H6 (Figure 3c ). Interestingly, H6 region is in close proximity to Prm2, which could explain the differential response of promoter regions 1 and 2 to hypoxia.
Finally, we cloned both EFNA3 promoter regions and studied their response to hypoxia and to the chemical inhibitor of HIF prolyl hydroxylases, dimethyloxalylglycine (DMOG), which causes acute HIF activation. Although both regions showed similar basal promoter activity (data not shown), Prm2 was strongly induced by hypoxia and DMOG, whereas Prm1 remained unaffected (Figure 3d ). Importantly, Prm2 response to hypoxia was critically The differences between groups were statistically significant (ANOVA F 4,10 = 21.9, P o0.001) and the asterisks indicate means pairs that were the statistically significant (*adjusted P o0.05; **adjusted Po0.01) in a posteriori Tukey's test. dependent on one of its RCGTG motifs whose mutation completely abrogated hypoxic induction (Figure 3d ).
HIF activation correlates with EFNA3 expression in human tumors
Over 80% of human ccRCC samples are deficient for VHL function and, as a consequence, present constitutive HIF activity even in the presence of oxygen. 14 Thus, ccRCC is highly suitable to study a putative link between HIF and EFNA3 in human tumors. In agreement, the expression of EGLN3, a well-characterized direct target of HIF, was clearly increased in the three independent ccRCC tumor series ( Figure 4a ). Similarly, EFNA3 was significantly increased in ccRCC tumor cells as compared with the normal kidney tissue in the same series, regardless of the microarray platform used to assay tumor samples ( Figure 4b ). The probes used to determine EFNA3 expression in these data sets bind to regions common to all transcripts from this locus (see Materials and methods), and thus they detect the cumulative signal by the mRNA and lncRNA transcripts. However, as the expression of lncRNAs was much higher than that of EFNA3 mRNA in all cell types and tissues tested so far (Figure 1, Supplementary Figure 2 and data not shown), we assume that the microarray signal is largely generated by the lncRNA. We also examined the expression of two other EFNA family members, EFNA1 and EFNA4, whose coding genes flank the EFNA3 locus in mammalian genomes. Interestingly, EFNA1, but not EFNA4, is induced by hypoxia (Yamashita et al. 24 and data not shown). Concordantly, the expression of EFNA1, but not that of EFNA4, is clearly increased in ccRCC (Figure 4) . These results rule out that the increased EFNA3 expression observed in these tumors could be caused by a gross structural alteration or transcriptional deregulation of the genomic region containing the EFNA3 gene and suggest that it is due to increased HIF activity, as it correlates with the changes observed for other hypoxia-regulated genes.
EFNA3 promotes metastatic behavior by enhancing extravasation of tumor cells As hypoxia is a common condition in solid tumors that correlates with metastatic potential 2 and some ephrin family members have been implicated in the promotion of metastatic behavior, 21 we next studied the metastatic potential of MDA-MB-231 cells engineered to express luciferase and EFNA3 in an orthotopic xenotransplantation model. At 5 weeks after tumor inoculation, the total photon flux was significantly higher in most animals bearing EFNA3-positive tumors, compared with controls ( Figures  5a and b) . Importantly, the luminiscence signal in EFNA3 animals was not restricted to the original injection site but diffused throughout the abdominal area, suggesting metastatic spread rather than increased primary tumor growth. In agreement, the volumes of the primary tumors did not differ significantly between groups at the end of the experiment (Figure 5c ) and necropsies confirmed that seven out of eight of the animals injected with EFNA3-positive cells presented with metastases as opposed to one out of seven in the control group (Figure 5d ). Most metastases were located in the peritoneal cavity, attached to the surface of internal organs (Figure 5e ). The increased metastatic potential of the expressing cells was confirmed in another mouse metastasis model where the same cells were injected via the tail vein to generate experimental lung metastases (Supplementary Figure 6) . Importantly, the microvascular density, as determined by analysis of CD31 staining, was similar between the EFNA3-positive and -negative tumors (Figures 5f and g) . Thus, the increased metastatic potential of EFNA3-expressing cells was not due to increased vascular density. Ephrins, through their receptors, mediate attraction and repulsion signals between cells. 17 This function could enable tumor cells entry and exit from blood vessels and in this way increase their metastatic potential. To test this possibility, we plated HEK293T cells, transiently transfected with plasmids encoding EFNA3, on top of the human umbilical vein endothelial cell (HUVEC) grown as a cell monolayer and measured the ability of HEK-EFNA3 cells to pass through HUVEC monolayer and attach to the plastic surface below. As shown in Figures 6a and b , the number of GFP-positive cells attached and spread on the plate was significantly higher when EFNA3 was expressed. These results are consistent with Ephrin-A3 transducing a repulsive signal to HUVECs that allowed HEK293T cells to transmigrate through the monolayer. In agreement, recombinant Ephrin-A3-Fc blocked the directional migration of HUVECs induced by the conditioned media from NIH 3T3 cells (Figure 6c ). These data suggest a mechanism for the increased metastatic potential of the tumors cells expressing EFNA3 whereby they can efficiently intravasate and extravasate through the vascular wall. To investigate this possibility in vivo, we injected MDA-MB-231 cells in the tail vein of immunodeficient mice and assessed the appearance of the individual tumoral cells in the lungs in a shortterm assay. Although the number of circulating tumor cells 2 h after injection was similar in the control and experimental groups, 7 days later the GFP signal was much higher in the animals injected with EFNA3-expressing cells (Figures 6d and e ). Collectively, these results suggest that Ephrin-A3 facilitates metastasis, at least in part, by allowing the extravasation of the tumor cells from the vasculature.
As the upregulation of Ephrin-A3 protein by hypoxia is mediated by the induction of EFNA3 lncRNAs, we next sought to investigate their effect on the metastatic potential of MDA-MB-231 cells. To that end, we generated cell lines overexpressing all the different transcripts from the EFNA3 locus and tested them in a zebrafish metastasis model. 38, 39 In agreement with the mouse models, expression of EFNA3 mRNA significantly increased the metastatic ability of MDA-MB-231 cells, as determined by the number of disseminated cells from the perivitelline cavity to the tail region of fish embryos (Figure 7) . This result confirms that Ephrin-A3 induced metastatic properties in very different model systems. Furthermore, this model allows the detection of individual metastatic cells in close association with the blood vessels (Figure 7a , white arrows), which resembles the results obtained in the lung seeding assay (Figures 6d and e ). Importantly, overexpression of any of the lncRNAs was sufficient to promote the dissemination of tumor cells to a degree similar, or even higher, to that conferred by EFNA3 mRNA. In agreement, the migration of HEK293T cells through a monolayer of endothelial cells was enhanced by the expression of EFNA3 lncRNAs ( Supplementary Figure 7) . Thus, the expression of either EFNA3 mRNA or lncRNA is sufficient to promote metastatic behavior.
In view of these results, we next analyzed the correlation between EFNA3 expression and the risk of metastasis in breast cancer patients. To this end, we made use of the public access data sets of human breast cancer gene expression and associated clinical data from the ROCK website (Online Breast Cancer Knowledgebase; http://www.rock.icr.ac.uk/). 40 We categorized patient samples according to EFNA3 expression level (high vs low) and analyzed the incidence of metastasis over time in both groups (Figure 8 ). In agreement with the results of the animal studies, the risk of metastatic disease was significantly higher in patients whose primary tumors expressed higher levels of EFNA3 (Figure 8 ). 
DISCUSSION
The majority of known HIF targets are regulated by direct induction of coding mRNA. In this study, using Ephrin A3 as an example, we suggest a novel way of hypoxic regulation of gene expression whereby the changes in the coding mRNA are only marginal. In this model, HIF directly regulates the levels of lncRNAs, which, in turn, increase protein levels by acting as competing endogenous RNAs that sequester miRNAs away from EFNA3 mRNA allowing for its translation. Interestingly, during the preparation of this manuscript, Choudhry et al. 41 reported an unexpected role for hypoxia in regulating lncRNA expression. On the other hand, the role of miRNAs in the hypoxic response is well documented. 42 Thus, it is likely that the complex mechanism described herein is not an isolated case but a more general theme in the regulation of gene expression by oxygen.
In spite of our data, further work is needed to fully understand the mechanism by which hypoxia regulates Ephrin-A3 expression. For example, a recent report describes how lncRNA that affects Uchl1 protein levels by enhancing mRNA translation of the coding mRNA. 43 Therefore, we cannot formally rule out that EFNA3encoded lncRNAs directly regulate EFNA3 mRNA translation rate. Similarly, we have not explored the possibility that EPAS1 could contribute to the accumulation of Ephrin-A3 during hypoxia by increasing its translation as has been reported for the EGFR. 44 Finally, we cannot completely discard an effect of hypoxia on EFNA3 mRNA transcription. Although the effect of hypoxia on EFNA3 mRNA level was relatively small in HeLa and MDA-MB-231 cells, and not detectable in VHL-deficient mice, we observed higher inductions in other cell lines such as LoVo and MCF7 (data not shown). As we found no evidences of regulation of EFNA3 mRNA by HIF (Figure 3) , the induction of EFNA3 mRNA by hypoxia could be a consequence of the different effects of miRNAs on gene expression, ranging from inhibition of translation to decrease mRNA stability. For example, as the relative proportion of the miRNAs binding to EFNA3 mRNA varies in different cell lines or conditions, their net effect on EFNA3 mRNA could change from preventing translation to affecting mRNA half-life. Alternatively, lncRNAs could also mediate the transcriptional induction of EFNA mRNA in a cell-specific manner. 29, 30 At any rate, our results highlight that EFNA3 response to hypoxia is tightly controlled and lncRNA induction has a key role on its regulation.
Regarding the mechanism responsible for the selective transcription of specific EFNA3 isoforms, we found that it is mediated by discriminatory recruitment of HIF and RNA Pol II to the Prm2 promoter region. Interestingly, the presence of CTCF binding sites flanking EFNA3 Prm2 region (Supplementary Figure 2 ) offers a plausible explanation for the preferential transcriptional activation of the lncRNA by HIF and the lack of the regulation of the canonical coding isoform. Other studies also demonstrate the role of insulators in determination of HIF specificity for promoters located in close proximity. 45 Also regarding the molecular mechanism, we found that in vitro EFNA3 induction was dependent on HIF-1α and not affected by HIF-2α knockdown, whereas in animal models, EPAS1 was required for EFNA3A induction upon VHL loss. Thus, HIF isoforms responsible for EFNA3 may be context-dependent and could be dictated by the availability of a specific HIF isoform, or another, HIF cell-typespecific transcription factor(s), that favor interaction with a specific HIF isoform. Nonetheless, this has been observed for other hypoxia-regulated genes. For instance, the hypoxic regulation of another ephrin, Ephrin-A1, also requires HIF1α 22 in cell cultures, but not in vivo, where it is dependent on HIF-2α. 24 An important question arising from our results relates to the role of Ephrin-A3 in the physiologic response to hypoxia. The induction of angiogenesis is one of the classical responses to hypoxia and other ephrins has key roles in angio-and vasculogenesis. However, we did not find a significant effect of Ephrin-A3 expression on tumor vascular density as determined by CD31 staining. Although we cannot rule out effects on other vascular parameters like maturation or normalization of tumor vasculature, our results demonstrate a direct role of Ephrin-A3 on tumor cell intra-/extravasation that could underlie the prometastatic action of this ephrin. Earlier studies showed that Ephrin-A3 overexpression prevents the in vitro formation of capillary-like structures by HUVECs. 34, 46 We similarly found that recombinant Ephrin-A3-Fc prevents the migration of HUVECs in vitro; however, these in vitro effects did not manifest in the in vivo models.
Regardless of their physiologic role, ephrins are frequently co-opted by the transformed cells whereby they contribute to the changes in cell-cell and cell-matrix attachment and survival during invasion, angiogenesis and metastasis. 17, 20 In agreement with this, we found that the expression of Ephrin-A3 in MDA-MB-231 breast cancer cells increased their metastatic potential. The significant correlation that we found between high EFNA3 levels and metastasis in clinical samples strongly supports this conclusion. Also in agreement with our findings, a recent study demonstrated the differential expression of Eprin-A3 between the highly metastatic and poorly metastatic colon cancer cells. 47 Although we have not formally demonstrated it, it is tempting to speculate that the correlation of hypoxia with metastasis risk observed in human tumors is, at least in part, explained by the induction of Ephrin-A3 downstream of HIF activation owing to the tumor hypoxia or oncogenic alterations. As for the mechanism, our results suggest that Ephrin-A3 promotes metastasis by repelling vascular endothelium and therefore creating points of intra-and extravasation for the tumor cells. Similar events are caused by angiopoietin-like 4 (ANGPTL4), another hypoxiainducible gene, to promote metastasis. 48 Importantly, we found that the expression of the lncRNAs is sufficient to promote metastasis, highlighting the relevance of this class of transcripts in the control of biologic processes and human disease.
In summary, we demonstrate a novel mechanism of hypoxic regulation, where EFNA3 expression is driven by previously nonannotated intragenic lncRNAs whose transcription is controlled by HIF. We propose that in hypoxic regions of solid tumors or in tumors harboring genetic alterations leading to constitutively active HIF, this novel mechanism leads to Ephrin-A3 accumulation and the promotion of metastasis.
MATERIALS AND METHODS
Cell culture
Cells were grown in standard culture conditions. For hypoxia treatments, cells were placed in a 1% O 2 , 5% CO 2 and 94% N 2 gas mixture in a Whitley hypoxystation (don Whitley Scientific, Bradford, UK). DMOG (Frontier Scientific, Oakland, CA, USA) was added, where indicated, at a 500 μM final concentration. MDA-MB231-EphrinA3-Luc and MDA-MB231-Luc cells were generated by infection with pLOC-EFNA3 or pLOC lentivirus, respectively, and then reinfected with Lenti-Fire Luciferase Luc2 (CellCyto, Beijing, China) lentivirus.
ChIP
ChIP was performed as described previously 49 with minor modifications. Briefly, EZ Chromatin Immunoprecipitation Kit (Millipore, Billerica, MA, USA) was used following the manufacturer's instructions. HeLa cells were grown to 85% confluence on 10 cm plates before they were exposed to hypoxia or left in normoxic conditions. Chromatin was immunoprecipitated with antibodies against RNA Pol II (Abcam, Cambridge, UK; 5408) or Hif1a (Abcam; ab2185). Mouse IgG (Sigma, St Louis, MO, USA; M8695) or whole rabbit serum were used as negative controls. DNA was purified by phenol-chloroform extraction and ethanol precipitation and bound regions were identified by qPCR with indicated primer pairs ( Supplementary Tables I and II) .
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